Your browser doesn't support javascript.
loading
Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling.
Strom, Nora I; Verhulst, Brad; Bacanu, Silviu-Alin; Cheesman, Rosa; Purves, Kirstin L; Gedik, Hüseyin; Mitchell, Brittany L; Kwong, Alex S; Faucon, Annika B; Singh, Kritika; Medland, Sarah; Colodro-Conde, Lucia; Krebs, Kristi; Hoffmann, Per; Herms, Stefan; Gehlen, Jan; Ripke, Stephan; Awasthi, Swapnil; Palviainen, Teemu; Tasanko, Elisa M; Peterson, Roseann E; Adkins, Daniel E; Shabalin, Andrey A; Adams, Mark J; Iveson, Matthew H; Campbell, Archie; Thomas, Laurent F; Winsvold, Bendik S; Drange, Ole Kristian; Børte, Sigrid; Ter Kuile, Abigail R; Nguyen, Tan-Hoang; Meier, Sandra M; Corfield, Elizabeth C; Hannigan, Laurie; Levey, Daniel F; Czamara, Darina; Weber, Heike; Choi, Karmel W; Pistis, Giorgio; Couvy-Duchesne, Baptiste; Van der Auwera, Sandra; Teumer, Alexander; Karlsson, Robert; Garcia-Argibay, Miguel; Lee, Donghyung; Wang, Rujia; Bjerkeset, Ottar; Stordal, Eystein; Bäckmann, Julia.
Afiliação
  • Strom NI; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Verhulst B; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
  • Bacanu SA; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
  • Cheesman R; Psychiatry and Behavioral Sciences, Texas A&M University, College Station, Texas, USA.
  • Purves KL; Psychiatry, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Gedik H; PROMENTA Centre, Department of Psychology, University of Oslo, Oslo, Norway.
  • Mitchell BL; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Kwong AS; Institute for Genomics in Health, Department of Psychiatry and Behavioral Sciences, State University of New York Downstate Health Sciences University, Brooklyn, New York, USA.
  • Faucon AB; Life Sciences, Integrative Life Sciences Doctoral Program, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Singh K; Human and Molecular Genetics, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Medland S; Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Colodro-Conde L; Faculty of Medicine, Queensland University , Brisbane, Queensland, Australia.
  • Krebs K; Bristol Medical School, Population Health Sciences, MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Hoffmann P; Centre for Clinical Brain Sciences, Division of Psychiatry, University of Edinburgh, Edinburgh, UK.
  • Herms S; Division of Medicine, Human Genetics, Vanderbilt University, Nashville, Tennessee, USA.
  • Gehlen J; Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Ripke S; Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Awasthi S; Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Palviainen T; Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Tasanko EM; School of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
  • Peterson RE; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Adkins DE; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
  • Shabalin AA; Department of Biomedicine, Human Genomics Research Group, University of Basel; University Hospital Basel, Basel, Switzerland.
  • Adams MJ; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
  • Iveson MH; Institute of Medical Genetics and Pathology, Medical Faculty, University Hospital Basel, Basel, Switzerland.
  • Campbell A; Department of Biomedicine, Human Genomics Research Group, University of Basel; University Hospital Basel, Basel, Switzerland.
  • Thomas LF; Center for Human Genetics, University of Marburg, Marburg, Germany.
  • Winsvold BS; Dept. of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Berlin, Germany.
  • Drange OK; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Børte S; Dept. of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Berlin, Germany.
  • Ter Kuile AR; Helsinki Institute of Life Science, Institute for Molecular Medicine Finland - FIMM, University of Helsinki, Helsinki, Finland.
  • Nguyen TH; Faculty of Medicine, Department of Psychology and Logopedics, SleepWell Research Program, University of Helsinki, Helsinki, Finland.
  • Meier SM; Institute for Genomics in Health, Department of Psychiatry and Behavioral Sciences, State University of New York Downstate Health Sciences University, Brooklyn, New York, USA.
  • Corfield EC; Psychiatry, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Hannigan L; School of Medicine, Department of Psychiatry, University of Utah, Salt Lake City, Utah, USA.
  • Levey DF; School of Medicine, Department of Psychiatry, University of Utah, Salt Lake City, Utah, USA.
  • Czamara D; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Weber H; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Choi KW; College of Medicine and Veterinary Medicine, Institute of Genetics and Cancer; Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK.
  • Pistis G; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Couvy-Duchesne B; HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
  • Van der Auwera S; BioCore - Bioinformatics Core Facility, Norwegian University of Science and Technology, Trondheim, Norway.
  • Teumer A; Clinic of Laboratory Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Karlsson R; Division of Clinical Neuroscience, Department of Research and Innovation, Oslo University Hospital, Oslo, Norway.
  • Garcia-Argibay M; Department of Public Health and Nursing, HUNT Center for Molecular and Clinical Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway.
  • Lee D; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Wang R; Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway.
  • Bjerkeset O; Division of Mental Health, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Stordal E; NORMENT Centre, University of Oslo, Oslo, Norway.
  • Bäckmann J; Centre of Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital and University of Oslo, Oslo, Norway.
medRxiv ; 2024 Jul 05.
Article em En | MEDLINE | ID: mdl-39006447
ABSTRACT
The major anxiety disorders (ANX; including generalized anxiety disorder, panic disorder, and phobias) are highly prevalent, often onset early, persist throughout life, and cause substantial global disability. Although distinct in their clinical presentations, they likely represent differential expressions of a dysregulated threat-response system. Here we present a genome-wide association meta-analysis comprising 122,341 European ancestry ANX cases and 729,881 controls. We identified 58 independent genome-wide significant ANX risk variants and 66 genes with robust biological support. In an independent sample of 1,175,012 self-report ANX cases and 1,956,379 controls, 51 of the 58 associated variants were replicated. As predicted by twin studies, we found substantial genetic correlation between ANX and depression, neuroticism, and other internalizing phenotypes. Follow-up analyses demonstrated enrichment in all major brain regions and highlighted GABAergic signaling as one potential mechanism underlying ANX genetic risk. These results advance our understanding of the genetic architecture of ANX and prioritize genes for functional follow-up studies.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha